Overnight, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) announced the pricing of its underwritten public offering of 2,000,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE